TGFB1 and Hepatic fibrosis: In a thioacetamide-induced liver fibrosis model in rats, oral administration of LF (200 mg/kg/day) and SM (50 mg/kg/day) significantly reduced collagen fibre deposition, decreased the expression of TGF-β1, and improved the grade of cirrhosis in both experimental groups [33].